Safeguard Scientifics Co-Leads $28M Series D for Crescendo Bioscience

Safeguard Scientifics Co-Leads $28M Series D for Crescendo Bioscience

[at noodls] – January 03, 2013 Molecular diagnostics company developed and is commercializing first and only multi-biomarker blood test-VectraTM DA-for rheumatoid arthritis to help physicians make more informed treatment … more

View todays social media effects on SFE

View the latest stocks trending across Twitter. Click to view dashboard

See who Safeguard is hiring next, click here to view

Share this post